Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics

Abstract

The occurrence of EPS in SGA users is a common finding, with no difference of antipsychotics studied in relation to the risk of extrapyramidal manifestations. The adjunctive use of carbamazepine may predispose the user of SGA to the occurrence of EPS.

Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review

“…Carbamazepine‐induced dyskinesias were reported due to intoxication67 or concomitant use of lithium 68. Interestingly, one study found that co‐administration of carbamazepine and a second‐generation antipsychotic increased the risk of movement disorders 69. In a study, 201 patients with epilepsy were evaluated by a movement disorders specialist for the presence of movement disorders.…”